If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.00
Bid: 102.00
Ask: 108.00
Change: 0.00 (0.00%)
Spread: 6.00 (5.882%)
Open: 105.00
High: 105.00
Low: 105.00
Prev. Close: 105.00
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2006 12:00

Intercede Group PLC31 March 2006 31 MARCH 2006 INTERCEDE GROUP PLC BOARD CHANGES Intercede Group plc (the "Company") is pleased to announce that it has appointedJacques Tredoux as a non-executive director of the Company, with effect from 31March 2006. Jacques Tredoux, aged 42, is the Chief Executive of Tredoux Capital Limited, acompany authorised by the Financial Services Authority to provide corporatefinance advisory services. Prior to establishing Tredoux Capital Limited, Jacques was the Chief ExecutiveOfficer of the Credo Group (UK) Limited, a group of companies in London thatprovides wealth management services. Members of the Credo Group have providedcorporate finance and fundraising assistance to the Company since prior to itsadmission to AIM. Jacques remains a director of Credo Group Holdings Limited. Jacques Tredoux qualified as a lawyer in 1988 in South Africa, and practised atEdward Nathan & Friedland Inc and Clifford Chance. Following the appointment of Jacques Tredoux, the Company also announces thatGreg Roediger has resigned as a non-executive director of the Company. Richard Parris, Chairman & CEO of the Company, commented: "We are extremely pleased that Jacques has agreed to join Intercede. He has awealth of legal, commercial and financial services experience which will be ofenormous value to us as we continue to expand and develop our network ofbusiness relationships across the world. "The Board would also like to take the opportunity to thank Greg for hisvaluable contribution to the Company's development over the past six years." APPENDIX The directorships held by Mr Tredoux over the five years preceding the date ofthis announcement other than in the Company are as follows: Current Directorships Companies registered in England & Wales: Tredoux Capital Limited Berkeley Corporation Limited Berkeley Management & Finance Limited Credo.com Limited Credo Advisory Services Limited Credo Corporate Finance Limited Credo Capital plc Credo Financial Solutions (UK) Limited Credo Group (UK) Limited Credo Guarantees Limited Credo Property Group Limited Credo Property Investments Limited Credo Property Management Limited Hooper Investments Limited Plastic Medical (Supplies) Limited Companies registered overseas: Credo Group Holdings Limited (Bermuda) Credo Australia Pty Limited (Australia) Credo Properties International Limited (Bermuda) Credo Sterling Properties UK Limited (BVI) San Mackenzie Enterprises Limited ("San Mackenzie") owns 1,463,216 shares whichrepresents 4.3% of the Company's issued share capital. San Mackenzie iscontrolled by The Woodcock Trust, of which Jacques Tredoux is a potentialbeneficiary. Jacques Tredoux has confirmed to the Company that there is no other informationrequired to be disclosed pursuant to the AIM Rules. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede's customers cover a range of industries and include Athena SmartcardSolutions, Department of Transport Ireland, Fujitsu, Getronics PinkRoccade,GemPlus, Lloyds TSB, UK National Health Service (NHS), UK Metropolitan Police,Oberthur Card Systems, RSA Security, Royal Bank of Scotland, SafeNet, Siemens,Thales, Ubizen, VeriSign and various US and UK Government agencies anddepartments. For more information, visit www.intercede.comIntercede and MyID are registered trademarks or trademarks in the UK and/or other countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public Relations Tel. +44 (0)20 7743 6679Archie Berens This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSNotice of Interim Results & Investor Presentation
20th Oct 20237:03 amRNSAppointment of Non-Executive Director
11th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSTrading Update
21st Sep 20231:31 pmRNSResult of AGM
4th Sep 20237:00 amRNSContract and Renewals Orders
30th Aug 20237:10 amRNSNotice of AGM and Publication of Annual Report
20th Jun 20237:01 amRNSBoard Changes
20th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSNotice of Results & Investor Presentation
27th Apr 20237:00 amRNSShare Incentive Plan
17th Apr 20237:00 amRNSTrading Update
3rd Apr 20237:00 amRNSContract wins/renewals
3rd Feb 202310:46 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSChange of Auditors
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
23rd Jan 20232:00 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSTrading Update
11th Jan 20232:30 pmRNSDirector/PDMR Shareholding
2nd Dec 20228:45 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSHalf-year Report
11th Nov 20227:00 amRNSNotice of Interim Results & Investor Presentation
13th Oct 202210:30 amRNSDirector/PDMR Shareholding
11th Oct 20221:00 pmRNSDirector/PDMR Shareholding
10th Oct 20228:00 amRNSLong Term Incentive Plan
10th Oct 20227:01 amRNSAcquisition of Authlogics Ltd
10th Oct 20227:00 amRNSTrading Update
28th Sep 202212:22 pmRNSResult of AGM
15th Sep 20227:00 amRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.